Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes

CONCLUSION: We conclude that a low serum EPO level is a predictive factor for responsiveness to ESAs in Asian patients with low-risk MDS.PMID:34967586 | DOI:10.31557/APJCP.2021.22.12.4037

Source: Asian Pacific Journal of Cancer Prevention - December 30, 2021 Category: Cancer & Oncology Authors: Saroj Hattakitpanitchakul Sirorat Kobbuaklee Kitsada Wudhikarn Chantana Polprasert Source Type: research